Fig. 2From: Comparison of SGLT2 inhibitors with DPP-4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus1-year event rates of MACE in the study population DPP-4i = dipeptidyl peptidase-4 inhibitors; IPTW = inverse probability of treatment weighting; MACE = major adverse composite event; SGLT2i = sodium-glucose cotransporter 2 inhibitorsBack to article page